Global Amphotericin B Market
Market Size in USD Billion
CAGR :
% 
 Forecast Period |
2023 –2030 |
 Market Size (Base Year) |
USD 0.22 Billion |
 Market Size (Forecast Year) |
USD 0.30 Billion |
 CAGR |
% |
| Major Markets Players |
|
Global Amphotericin B Market, By Product Type (Static Drops, Atomization Inhalation, Local Lesion Injection, Other), Application (Vaginitis, Candida Infection, Leishmaniasis, Kala-Azar, Cryptococcal Infection, Aspergillus Infection, Other), Route of Administration (Intravenous, Parenteral, Oral, Other), Drug Class (Antifungals, Systemic, Other), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Industry Trends and Forecast to 2030.
Amphotericin B Market Analysis and Size
Rise in the prevalence of fungal infections, emerging markets, rise in healthcare expenditure and growing government funds and initiatives for spreading awareness are the factors that will expand the global amphotericin B market. Rising R&D activities and clinical trials will provide beneficial opportunities for the global amphotericin B market in the forecast period of 2023-2030. Rise in the population that possess antifungal drug resistance and side effects of Amphotericin B such as blue lips, seizures, abdominal pain, numbness, fever, and other common effects are the factors that will hamper the market growth and will further challenge the global amphotericin B market in the forecast period.
Data Bridge Market Research analyzes that the global amphotericin b market which was USD 0.22 billion in 2022, would rocket up to USD 0.30 billion by 2030, and is expected to undergo a CAGR of 4.6% during the forecast period 2023 to 2030. This indicates the market value. “static drops” dominates the product segment of the global amphotericin b market owing to the increasing number of fungal diseases. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Amphotericin B Market Scope and Segmentation
|
Report Metric |
Details |
|
Forecast Period |
2023 to 2030 |
|
Base Year |
2022 |
|
Historic Year |
2021 (Customizable to 2015-2020) |
|
Quantitative Units |
Revenue in USD Million, Volumes in Units, Pricing in USD |
|
Segments Covered |
By Product Type (Static Drops, Atomization Inhalation, Local Lesion Injection, Other), Application (Vaginitis, Candida Infection, Leishmaniasis, Kala-Azar, Cryptococcal Infection, Aspergillus Infection, Other), Route of Administration (Intravenous, Parenteral, Oral, Other), Drug Class (Antifungals, Systemic, Other), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) |
|
Countries Covered |
U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, and rest of South America |
|
Market Players Covered |
Bristol-Myers Squibb Company (US), MATINAS BIOPHARMA HOLDINGS, INC. (US), Nano-X Imaging LTD. (Israel), Nanomerics (UK), DNDi (Geneva), Abzena Ltd (UK), Bharat Serums and Vaccines Limited (BSV) (India), Astellas Pharma Inc.(Japan), Leadiant Biosciences (Italy), Inc., Lilly (US), InterMune (US), Jina Pharmaceuticals (US), SteriMax (India), and XGen Pharmaceuticals DJB, Inc. (US) among other |
|
Market Opportunities |
|
Market Definition
Amphotericin B is a polyene antifungal antibiotic which is produced by Streptomyces nodosus. It is used for the treatment of fungal infections in neutropenic patients, cryptococcal meningitis in HIV infection, fungal infections, and leishmaniasis. It acts by stopping the growth of fungi as it binds to ergosterol (an important component of fungal membrane). It further causes depolarization of the membrane and altering cell membrane permeability which leads to leakage of important intracellular components, cell rupture, and results in cell death. It is given by injection into a vein.
Amphotericin B Market Dynamics
Drivers
- Increase in cases of hospital acquired infection
Hospital-acquired infections (HAIs) can indeed contribute to an increase in the demand for medications such as Amphotericin B, which is an antifungal medication. HAIs are infections that patients acquire during their stay in a healthcare facility, including hospitals, clinics, and long-term care facilities. These infections can be caused by bacteria, viruses, fungi, or other pathogens, and they pose a significant challenge to patient care and overall healthcare systems.
- Increase in demand for effective antifungal drugs
Fungal infections have been on the rise globally, affecting various populations, including immunocompromised individuals, patients with chronic diseases, and those undergoing invasive medical procedures. Factors such as the aging population, increased use of immunosuppressive therapies, and the spread of drug-resistant fungal strains contribute to the growing incidence of fungal infections.
Opportunities
Growing unhygienic practices
Unhygienic practices and the presence of hospital-acquired infections are significant concerns for patient safety and public health. These practices can lead to increased rates of infections and pose serious risks to patients.
Restraints/Challenges
High investment requirements
However, obstacles such as high investment requirements, high treatment costs, and expensive capital expenditure on equipment are expected to stymie market expansion, as are technical challenges with sample collection and a lack of suitable reimbursement.
This global amphotericin b market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyzes opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, and technological innovations in the market. To gain more info on the surgical microscopes market contact Data Bridge Market Research for an Analyst Brief, our team will help you make an informed market decision to achieve market growth.
Recent Developments
- In 2021, SP Accure Labs announced launching of amphotericin B emulsion. This drug is used in treatment of mucormycosis
- In 2021, Celon Laboratories announced launching of amphotericin B emulsion. This drug can be used in treatment of mucormycosis commonly known as black fungus
- In 2021, TLC a drug maker company announced the launch of liposomal amphotericin B in India. The product is named AmphoTLC and can be effective in the treatment of mucormycosis
Global Amphotericin B Market Scope
The global amphotericin b market is segmented on the basis of product type, application, route of administration, drug class, end-users, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product Type
- STATIC DROPS,
- ATOMIZATION INHALATION,
- LOCAL LESION INJECTION,
- OTHER
Application
- VAGINITIS
- CANDIDA INFECTION
- LEISHMANIASIS
- KALA-AZAR
- CRYPTOCOCCAL INFECTION
- ASPERGILLUS INFECTION
- OTHER
Route Of Administration
- INTRAVENOUS
- PARENTERAL
- ORAL
- OTHERS
Drug Class
- ANTIFUNGALS
- SYSTEMIC
- OTHER
End User
- CLINIC
- HOSPITAL
- OTHERS
Distribution Channel
- HOSPITAL PHARMACY
- RETAIL PHARMACY
- ONLINE PHARMACY
Global Amphotericin B Market Regional Analysis/Insights
The global amphotericin b market is analyzed and market size insights and trends are provided by country, product type, application, route of administration, drug class, end-users, and distribution channel as referenced above.
The countries covered in the global amphotericin b market report are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, and rest of South America.
North America dominates the global amphotericin b market because of the increasing healthcare initiatives, the strong presence of major players in the market, increasing cases of chronic fungal conditions and rising number of research activities in this region.
Asia-Pacific is expected to witness significant growth during the forecast period of 2023 to 2030 due to the increase in government initiatives to promote awareness, growing research activities in the region, availability of massive untapped markets, large population pool, and the growing demand for quality healthcare in the region.
The country section of the report also provides individual market-impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points like downstream and upstream value chain analysis, technical trends, Porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The global amphotericin b market also provides you with detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the global rare biomarkers market, the impact of technology using lifeline curves and changes in healthcare regulatory scenarios and their impact on the surgical microscopes market. The data is available for the historic period 2010-2020.
Competitive Landscape and Global Amphotericin B Market Share Analysis
The global amphotericin b market competitive landscape provides details of competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus related to the market.
Some of the major players operating in the global amphotericin b market are:
- Bristol-Myers Squibb Company (US)
- MATINAS BIOPHARMA HOLDINGS, INC. (US)
- Nano-X Imaging LTD. (Israel)
- Nanomerics (UK)
- DNDi (Geneva)
- Abzena Ltd (UK)
- Bharat Serums and Vaccines Limited (BSV) (India)
- Astellas Pharma Inc.(Japan)
- Leadiant Biosciences (Italy), Inc.
- Lilly (US), InterMune (US)
- Jina Pharmaceuticals (US)
- SteriMax (India)
- XGen Pharmaceuticals DJB, Inc. (US)
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
